Transforming clinical research in the United States : challenges and opportunities : workshop summary /

Saved in:
Bibliographic Details
Imprint:Washington, D.C. : National Academies Press, ©2010.
Description:1 online resource (xvii, 131 pages) : illustrations (some color), color maps
Language:English
Series:Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11245822
Hidden Bibliographic Details
Other authors / contributors:English, Rebecca A.
Lebovitz, Yeonwoo.
Giffin, Robert B.
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
ISBN:9780309153331
0309153336
1282917021
9781282917026
9780309153324
0309153328
9786612917028
6612917024
Digital file characteristics:data file
Notes:Includes bibliographical references (pages 103-105).
English.
Print version record.
Summary:"An ideal health care system relies on efficiently generating timely, accurate evidence to deliver on its promise of diminishing the divide between clinical practice and research. There are growing indications, however, that the current health care system and the clinical research that guides medical decisions in the United States falls far short of this vision. The process of generating medical evidence through clinical trials in the United States is expensive and lengthy, includes a number of regulatory hurdles, and is based on a limited infrastructure. The link between clinical research and medical progress is also frequently misunderstood or unsupported by both patients and providers. The focus of clinical research changes as diseases emerge and new treatments create cures for old conditions. As diseases evolve, the ultimate goal remains to speed new and improved medical treatments to patients throughout the world. To keep pace with rapidly changing health care demands, clinical research resources need to be organized and on hand to address the numerous health care questions that continually emerge. Improving the overall capacity of the clinical research enterprise will depend on ensuring that there is an adequate infrastructure in place to support the investigators who conduct research, the patients with real diseases who volunteer to participate in experimental research, and the institutions that organize and carry out the trials. To address these issues and better understand the current state of clinical research in the United States, the Institute of Medicine's (IOM) Forum on Drug Discovery, Development, and Translation held a 2-day workshop entitled Transforming Clinical Research in the United States. The workshop, summarized in this volume, laid the foundation for a broader initiative of the Forum addressing different aspects of clinical research. Future Forum plans include further examining regulatory, administrative, and structural barriers to the effective conduct of clinical research; developing a vision for a stable, continuously funded clinical research infrastructure in the United States; and considering strategies and collaborative activities to facilitate more robust public engagement in the clinical research enterprise."--Publisher's description.
Other form:Print version: Transforming clinical research in the United States. Washington, D.C. : National Academies Press, ©2010 9780309153324

MARC

LEADER 00000cam a2200000Ia 4500
001 11245822
005 20210426223034.4
006 m o d
007 cr cnu---unuuu
008 110222s2010 dcuab ob 100 0 eng d
010 |a  2012405266 
016 7 |a 101551948  |2 DNLM 
016 7 |a 015768336  |2 Uk 
019 |a 671955048  |a 747946222  |a 764547524  |a 816622936  |a 961538433  |a 962633609  |a 971069514  |a 978006322  |a 988475676  |a 991992286  |a 1021274730  |a 1028787576  |a 1037918390  |a 1038702471  |a 1047574160  |a 1048145019  |a 1055340812  |a 1064769359  |a 1081198660  |a 1109375479  |a 1119419251  |a 1119424940  |a 1119437654  |a 1120827183  |a 1153562427  |a 1156326930  |a 1159641157  |a 1204376719  |a 1204386004  |a 1227640658  |a 1228620405  |a 1229745284 
020 |a 9780309153331  |q (electronic bk.) 
020 |a 0309153336  |q (electronic bk.) 
020 |a 1282917021 
020 |a 9781282917026 
020 |z 9780309153324 
020 |z 0309153328 
020 |a 9786612917028 
020 |a 6612917024 
035 |a (OCoLC)703252903  |z (OCoLC)671955048  |z (OCoLC)747946222  |z (OCoLC)764547524  |z (OCoLC)816622936  |z (OCoLC)961538433  |z (OCoLC)962633609  |z (OCoLC)971069514  |z (OCoLC)978006322  |z (OCoLC)988475676  |z (OCoLC)991992286  |z (OCoLC)1021274730  |z (OCoLC)1028787576  |z (OCoLC)1037918390  |z (OCoLC)1038702471  |z (OCoLC)1047574160  |z (OCoLC)1048145019  |z (OCoLC)1055340812  |z (OCoLC)1064769359  |z (OCoLC)1081198660  |z (OCoLC)1109375479  |z (OCoLC)1119419251  |z (OCoLC)1119424940  |z (OCoLC)1119437654  |z (OCoLC)1120827183  |z (OCoLC)1153562427  |z (OCoLC)1156326930  |z (OCoLC)1159641157  |z (OCoLC)1204376719  |z (OCoLC)1204386004  |z (OCoLC)1227640658  |z (OCoLC)1228620405  |z (OCoLC)1229745284 
035 9 |a (OCLCCM-CC)703252903 
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCA  |d YDXCP  |d E7B  |d IDEBK  |d VPI  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCO  |d NLGGC  |d VAM  |d MMU  |d CDX  |d EBLCP  |d OCLCQ  |d VT2  |d OCLCQ  |d AGLDB  |d TOA  |d MOR  |d OCLCO  |d PIFAG  |d ZCU  |d OCLCO  |d OCLCQ  |d MERUC  |d OCLCO  |d OCLCQ  |d NJR  |d OCLCO  |d MERER  |d OCLCO  |d OCLCA  |d U3W  |d OCLCA  |d BUF  |d OCLCO  |d OCLCQ  |d OCLCO  |d CUY  |d KIJ  |d OCLCO  |d OCLCQ  |d OCLCF  |d OCLCO  |d STF  |d VNS  |d WRM  |d OCLCO  |d OCLCQ  |d VTS  |d EZ9  |d OCLCQ  |d ICG  |d OCLCO  |d AU@  |d OCLCO  |d WYU  |d OCLCO  |d OCLCQ  |d S9I  |d REC  |d OCLCQ  |d DKC  |d OCLCO  |d OCLCQ  |d M8D  |d OCLCO  |d UX1  |d OCLCQ  |d OCLCO  |d HS0  |d LIP  |d UKAHL  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA  |d UKCRE  |d UKBTH  |d LVT  |d OCLCO 
043 |a n-us--- 
049 |a MAIN 
050 4 |a R853.C55  |b T73 2010eb 
060 4 |a 2011 A-819 
060 4 |a QV 771 
072 7 |a MED  |x 106000  |2 bisacsh 
072 7 |a MBGR  |2 bicssc 
245 0 0 |a Transforming clinical research in the United States :  |b challenges and opportunities : workshop summary /  |c Rebecca A. English, Yeanwoo Lebovitz, and Robert B. Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. 
260 |a Washington, D.C. :  |b National Academies Press,  |c ©2010. 
300 |a 1 online resource (xvii, 131 pages) :  |b illustrations (some color), color maps 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
504 |a Includes bibliographical references (pages 103-105). 
505 0 |a Introduction -- The state of clinical research in the United States: an overview -- Challenges in clinical research -- Clinical trials in cardiovascular disease -- Clinical trials in depression -- Clinical trials in cancer -- Clinical trials in diabetes -- Building a robust clinical trials infrastructure. 
520 |a "An ideal health care system relies on efficiently generating timely, accurate evidence to deliver on its promise of diminishing the divide between clinical practice and research. There are growing indications, however, that the current health care system and the clinical research that guides medical decisions in the United States falls far short of this vision. The process of generating medical evidence through clinical trials in the United States is expensive and lengthy, includes a number of regulatory hurdles, and is based on a limited infrastructure. The link between clinical research and medical progress is also frequently misunderstood or unsupported by both patients and providers. The focus of clinical research changes as diseases emerge and new treatments create cures for old conditions. As diseases evolve, the ultimate goal remains to speed new and improved medical treatments to patients throughout the world. To keep pace with rapidly changing health care demands, clinical research resources need to be organized and on hand to address the numerous health care questions that continually emerge. Improving the overall capacity of the clinical research enterprise will depend on ensuring that there is an adequate infrastructure in place to support the investigators who conduct research, the patients with real diseases who volunteer to participate in experimental research, and the institutions that organize and carry out the trials. To address these issues and better understand the current state of clinical research in the United States, the Institute of Medicine's (IOM) Forum on Drug Discovery, Development, and Translation held a 2-day workshop entitled Transforming Clinical Research in the United States. The workshop, summarized in this volume, laid the foundation for a broader initiative of the Forum addressing different aspects of clinical research. Future Forum plans include further examining regulatory, administrative, and structural barriers to the effective conduct of clinical research; developing a vision for a stable, continuously funded clinical research infrastructure in the United States; and considering strategies and collaborative activities to facilitate more robust public engagement in the clinical research enterprise."--Publisher's description. 
588 0 |a Print version record. 
546 |a English. 
650 0 |a Clinical trials  |z United States  |v Congresses. 
650 0 |a Clinical trials  |x Research  |z United States  |v Congresses. 
650 0 |a Clinical trials  |x Government policy  |z United States  |v Congresses. 
650 2 |a Drug Discovery  |v Congresses  |z United States. 
650 2 |a Public Policy  |v Congresses  |z United States. 
650 2 |a Clinical Trials as Topic  |v Congresses  |z United States. 
650 1 2 |a Clinical Trials as Topic  |z United States  |v Congresses. 
650 1 2 |a Biomedical Research  |z United States  |v Congresses. 
650 2 2 |a Research Design  |z United States  |v Congresses. 
650 2 2 |a Evidence-Based Medicine  |z United States  |v Congresses. 
650 2 2 |a Drug Discovery. 
650 2 2 |a Public Policy. 
650 1 2 |a Biomedical Research. 
650 2 2 |a Research Design. 
650 2 2 |a Evidence-Based Medicine. 
650 1 2 |a Clinical Trials as Topic. 
651 2 |a United States. 
650 7 |a MEDICAL  |x Research.  |2 bisacsh 
650 7 |a Clinical trials.  |2 fast  |0 (OCoLC)fst00864429 
650 7 |a Clinical trials  |x Government policy.  |2 fast  |0 (OCoLC)fst00864433 
651 7 |a United States.  |2 fast  |0 (OCoLC)fst01204155 
655 0 |a Electronic book. 
655 2 |a Congress. 
655 4 |a Electronic books. 
655 7 |a Conference papers and proceedings.  |2 fast  |0 (OCoLC)fst01423772 
655 7 |a Electronic books.  |2 lcgft 
700 1 |a English, Rebecca A.  |0 http://id.loc.gov/authorities/names/no2010177259 
700 1 |a Lebovitz, Yeonwoo.  |0 http://id.loc.gov/authorities/names/no2010177280 
700 1 |a Giffin, Robert B.  |0 http://id.loc.gov/authorities/names/no96041278 
710 2 |a Institute of Medicine (U.S.).  |b Forum on Drug Discovery, Development, and Translation.  |0 http://id.loc.gov/authorities/names/no2007051854 
776 0 8 |i Print version:  |t Transforming clinical research in the United States.  |d Washington, D.C. : National Academies Press, ©2010  |z 9780309153324  |w (OCoLC)658581476 
830 0 |a Online access: National Academy of Sciences National Academies Press. 
830 0 |a Online access: NCBI NCBI Bookshelf. 
856 4 0 |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=349280  |y eBooks on EBSCOhost 
856 4 0 |u http://www.nap.edu/catalog.php?record_id=12900  |y National Academies Press 
903 |a HeVa 
929 |a oclccm 
999 f f |i eb729af6-e0c1-5fec-9bb5-a24f2c6e7103  |s c7cc10f6-ce42-5088-bcf2-288dc579537d 
928 |t Library of Congress classification  |a R853.C55 T73 2010eb  |l Online  |c UC-FullText  |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=349280  |z eBooks on EBSCOhost  |g ebooks  |i 12300876 
928 |t Library of Congress classification  |a R853.C55 T73 2010eb  |l Online  |c UC-FullText  |u http://www.nap.edu/catalog.php?record_id=12900  |z National Academies Press  |g ebooks  |i 12300877